PND2- COMPARISON OF ADVERSE REACTION REPORTS FOR RIVASTIGMINE AND DONEPEZIL USING THE FDAS ADVERSE EVENT REPORTING SYSTEM

Sep 1, 2001, 00:00 AM
10.1016/S1098-3015(11)71778-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)71778-8/fulltext
Section Title :
Section Order : 292
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71778-8&doi=10.1016/S1098-3015(11)71778-8
HEOR Topics :
Tags :
Regions :